All News

    September Blood Cancer Updates: What Patients Should Know

    October 2nd 2025, 4:00pm

    Article

    Recent clinical trial results, real-world safety data, and patient experiences highlight meaningful advances in blood cancer care.

    FDA Approves Guardant360 Test With Inluriyo for ESR1 Breast Cancer

    October 2nd 2025, 3:00pm

    Article

    The FDA approved Guardant360 CDx to identify adults with ESR1-mutated, ER-positive, HER2-negative breast cancer eligible for treatment with Inluriyo.

    Pelvic Physical Therapy After Cancer Restores Intimacy, Wellness

    October 2nd 2025, 1:00pm

    Video

    Alison Ankiewicz explains how pelvic physical therapy restores tissue, sexual function and emotional confidence for patients after cancer treatment.

    2025 Quarter 3 – COA Patient Advocacy Network News Bulletin

    October 2nd 2025, 12:44pm

    Article

    CPAN begins the fourth quarter with a continued focus on its core mission: education.

    How PBMs Are Blocking Patient Access to Medication: A CPAN Advocacy Chat

    October 2nd 2025, 12:29pm

    Article

    You don’t want to miss the upcoming CPAN Advocacy Chat, we hope you can join us!

    Finding Strength and Advocacy During Breast Cancer Awareness Month

    October 1st 2025, 9:00pm

    Article

    Jennie Smythe, a breast cancer survivor, shared her journey from diagnosis to survivorship in an interview with CURE during Breast Cancer Awareness Month.

    Esophageal Cancer, From Diagnosis to Treatment

    October 1st 2025, 8:00pm

    Article

    A diagnosis of esophageal cancer can bring up many questions and concerns. Our goal is to provide you with clear, accurate and educational information.

    All FDA Oncology Approvals From September 2025

    October 1st 2025, 7:00pm

    Article

    In September 2025, the FDA approved new treatments for breast, bladder and prostate cancers, plus biosimilars and a subcutaneous immunotherapy option.

    Living with Lynch Syndrome

    October 1st 2025, 5:00pm

    Article

    Oct. 1, Previvor Day, acknowledges us who carry a hereditary cancer syndrome or genetic mutation that significantly increases our risk of cancer.

    Twice-Daily Radiation Boosts Quality of Life in Small Cell Lung Cancer

    October 1st 2025, 4:00pm

    Article

    Adding Tecentriq to chemoradiation improved quality of life and supported twice-daily radiation for patients with limited-stage small cell lung cancer.